Jiuzhou Wang

49 total papers · 1.5k total citations
33 papers, 988 citations indexed

About

Jiuzhou Wang is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiuzhou Wang has authored 33 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Reproductive Medicine and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiuzhou Wang's work include Ovarian cancer diagnosis and treatment (14 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (6 papers). Jiuzhou Wang is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (6 papers). Jiuzhou Wang collaborates with scholars based in United States, Spain and Italy. Jiuzhou Wang's co-authors include Marc G. Genton, Ursula A. Matulonis, Ana Oaknin, Michael Method, Julie D. Horan, Margaret A. Foley, Frances A. Shepherd, Philip C. Hoffman, Wilfried Eberhardt and David R. Spigel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jiuzhou Wang

31 papers receiving 959 citations

Hit Papers

Efficacy and Safety of Mi... 2023 2026 2024 2023 2023 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
    2023 210 citations Ursula A. Matulonis, Domenica Lorusso et al. Journal of Clinical Oncology profile →
  2. Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer
    2023 76 citations Lucy Gilbert, Ana Oaknin et al. Gynecologic Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jiuzhou Wang 511 367 222 191 117 33 988
Akihiro Hirakawa 483 0.9× 278 0.8× 38 0.2× 146 0.8× 88 0.8× 60 1.0k
Pralay Mukhopadhyay 579 1.1× 225 0.6× 29 0.1× 144 0.8× 56 0.5× 41 878
Bronislava M. Sigal 418 0.8× 212 0.6× 92 0.4× 32 0.2× 159 1.4× 18 989
Geoffrey Kim 615 1.2× 348 0.9× 43 0.2× 36 0.2× 58 0.5× 29 1.0k
Giovanni M. Bariani 433 0.8× 196 0.5× 115 0.5× 28 0.1× 29 0.2× 32 818
Jana Barinoff 593 1.2× 269 0.7× 117 0.5× 18 0.1× 164 1.4× 49 973
Fabian Zohren 281 0.5× 665 1.8× 48 0.2× 43 0.2× 192 1.6× 44 1.0k
R.D. Gelber 548 1.1× 146 0.4× 27 0.1× 69 0.4× 95 0.8× 30 1.0k
Harvey Brodovsky 477 0.9× 252 0.7× 197 0.9× 18 0.1× 27 0.2× 32 980
Ernesto Wasserman 810 1.6× 357 1.0× 36 0.2× 43 0.2× 132 1.1× 35 1.2k

Countries citing papers authored by Jiuzhou Wang

Since Specialization
Citations

This map shows the geographic impact of Jiuzhou Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiuzhou Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiuzhou Wang more than expected).

Fields of papers citing papers by Jiuzhou Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiuzhou Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiuzhou Wang. The network helps show where Jiuzhou Wang may publish in the future.

Co-authorship network of co-authors of Jiuzhou Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiuzhou Wang. A scholar is included among the top collaborators of Jiuzhou Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiuzhou Wang. Jiuzhou Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise Hainline Breakdown of academic impact, for papers by Bob Walrave Breakdown of academic impact, for papers by Giorgio Amati Breakdown of academic impact, for papers by Giulia Fava Breakdown of academic impact, for papers by Patrice Dumain Breakdown of academic impact, for papers by Monika Součková Breakdown of academic impact, for papers by Jill Downie Breakdown of academic impact, for papers by Thiago Santini
Rankless by CCL
2026